Elicio Logo

Elicio

Developer, Investor

Powered by wind

#101 of 1783 Developers#124 of 1639 Investors

Why Elicio Therapeutics Inc (ELTX) Is Skyrocketing So Far In 2025

04 Feb

Sovereign Wealth Fund Institute
Read on ca.finance.yahoo.com

Elicio: Lymph Node Binding With ELI-002 Could Lead To Substantial H1 2025 Data

31 Jan

Sovereign Wealth Fund Institute
Read on seekingalpha.com

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | Taiwan News | Jan. 30, 2025 21:00

30 Jan

Sovereign Wealth Fund Institute
Read on taiwannews.com.tw

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Elicio Therapeutics (NASDAQ:ELTX)

30 Jan

Sovereign Wealth Fund Institute
Read on benzinga.com

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market ...

30 Jan

Sovereign Wealth Fund Institute
Read on eagletribune.com

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

22 Jan

Sovereign Wealth Fund Institute
Read on manilatimes.net

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 | Business Upturn

12 Dec

Sovereign Wealth Fund Institute
Read on businessupturn.com

Elicio Therapeutics (ELTX) Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study

12 Dec

Sovereign Wealth Fund Institute
Read on streetinsider.com

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 | Taiwan News | Dec. 12, 2024 20:00

12 Dec

Sovereign Wealth Fund Institute
Read on taiwannews.com.tw

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 - Elicio Therapeutics (NASDAQ:ELTX)

12 Dec

Sovereign Wealth Fund Institute
Read on benzinga.com